Mengis Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.35M | Buy |
96,327
+1,450
| +2% | +$139K | 1.44% | 19 |
|
|
2025
Q4 | $9.11M | Buy |
94,877
+2,785
| +3% | +$271K | 1.61% | 15 |
|
|
2025
Q3 | $8.77M | Buy |
92,092
+150
| +0.2% | +$13.8K | 1.72% | 12 |
|
|
2025
Q2 | $8.01M | Sell |
91,942
-37
| -0% | -$3.14K | 1.7% | 13 |
|
|
2025
Q1 | $8.27M | Buy |
91,979
+735
| +0.8% | +$65.8K | 1.73% | 14 |
|
|
2024
Q4 | $7.29M | Buy |
91,244
+1,871
| +2% | +$162K | 1.49% | 16 |
|
|
2024
Q3 | $8.05M | Buy |
89,373
+1,116
| +1% | +$93.9K | 1.58% | 14 |
|
|
2024
Q2 | $6.95M | Buy |
88,257
+17,820
| +25% | +$1.46M | 1.41% | 17 |
|
|
2024
Q1 | $6.14M | Sell |
70,437
-20,240
| -22% | -$1.73M | 0.95% | 22 |
|
|
2023
Q4 | $7.47M | Buy |
90,677
+3,462
| +4% | +$264K | 1.4% | 18 |
|
|
2023
Q3 | $6.83M | Buy |
87,215
+224
| +0.3% | +$18.8K | 1.42% | 19 |
|
|
2023
Q2 | $7.66M | Buy |
86,991
+4,152
| +5% | +$357K | 1.53% | 18 |
|
|
2023
Q1 | $6.68M | Buy |
82,839
+26,025
| +46% | +$2.12M | 1.41% | 18 |
|
|
2022
Q4 | $4.42M | Buy |
56,814
+33,718
| +146% | +$2.73M | 0.96% | 25 |
|
|
2022
Q3 | $1.86M | Buy |
23,096
+6,110
| +36% | +$549K | 0.44% | 60 |
|
|
2022
Q2 | $1.52M | Buy |
16,986
+4,510
| +36% | +$457K | 0.33% | 68 |
|
|
2022
Q1 | $1.38M | Buy |
12,476
+4,635
| +59% | +$490K | 0.27% | 79 |
|
|
2021
Q4 | $811K | Buy |
7,841
+2,130
| +37% | +$247K | 0.15% | 105 |
|
|
2021
Q3 | $715K | Sell |
5,711
-71
| -1% | -$9.19K | 0.15% | 111 |
|
|
2021
Q2 | $717K | Hold |
5,782
| – | – | 0.15% | 113 |
|
|
2021
Q1 | $683K | Buy |
5,782
+55
| +1% | +$6.45K | 0.15% | 110 |
|
|
2020
Q4 | $670K | Buy |
5,727
+700
| +14% | +$77.1K | 0.16% | 107 |
|
|
2020
Q3 | $522K | Hold |
5,027
| – | – | 0.14% | 106 |
|
|
2020
Q2 | $460K | Buy |
5,027
+32
| +0.6% | +$3.07K | 0.14% | 110 |
|
|
2020
Q1 | $450K | Hold |
4,995
| – | – | 0.15% | 108 |
|
|
2019
Q4 | $566K | Hold |
4,995
| – | – | 0.16% | 108 |
|
|
2019
Q3 | $542K | Buy |
4,995
+80
| +2% | +$8.35K | 0.16% | 111 |
|
|
2019
Q2 | $478K | Buy |
+4,915
| New | +$449K | 0.15% | 116 |
|
|
2018
Q1 | – | Sell |
-3,146
| Closed | -$254K | – | 123 |
|
|
2017
Q4 | $254K | Sell |
3,146
-350
| -10% | -$28K | 0.15% | 108 |
|
|
2017
Q3 | $271K | Sell |
3,496
-50
| -1% | -$4.15K | 0.18% | 103 |
|
|
2017
Q2 | $314K | Hold |
3,546
| – | – | 0.22% | 95 |
|
|
2017
Q1 | $285K | Sell |
3,546
-550
| -13% | -$43K | 0.21% | 99 |
|
|
2016
Q4 | $291K | Sell |
4,096
-100
| -2% | -$7.86K | 0.23% | 92 |
|
|
2016
Q3 | $362K | Sell |
4,196
-800
| -16% | -$69.7K | 0.3% | 83 |
|
|
2016
Q2 | $433K | Hold |
4,996
| – | – | 0.38% | 74 |
|
|
2016
Q1 | $374K | Sell |
4,996
-75
| -1% | -$5.65K | 0.35% | 77 |
|
|
2015
Q4 | $390K | Sell |
5,071
-4,100
| -45% | -$309K | 0.34% | 79 |
|
|
2015
Q3 | $613K | Hold |
9,171
| – | – | 0.57% | 60 |
|
|
2015
Q2 | $679K | Hold |
9,171
| – | – | 0.57% | 58 |
|
|
2015
Q1 | $715K | Buy |
9,171
+71
| +0.8% | +$5.38K | 0.62% | 56 |
|
|
2014
Q4 | $657K | Buy |
+9,100
| New | +$632K | 0.63% | 53 |
|
Other funds holding MDT
VCM
VPM
Mengis Capital Management's MDT Position: Q1 2026 in Review
Mengis Capital Management increased its Medtronic (MDT) stake by 1.5% in Q1 2026, buying an estimated $139K and bringing the position to 96,327 shares worth $8.35M. The position accounts for 1.44% of the portfolio, ranked #19.
Mengis Capital Management first reported a position in MDT in Q4 2014 and has held it in 41 quarters since. The position peaked at $9.11M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Mengis Capital Management held 96,327 shares of Medtronic worth $8.35M as of Q1 2026.
- Mengis Capital Management bought 1,450 Medtronic shares in Q1 2026, an estimated $139K.
- Medtronic made up 1.44% of Mengis Capital Management's portfolio in Q1 2026, its #19 holding.
- Mengis Capital Management first reported a position in Medtronic in Q4 2014 and has held it in 41 quarters since.
- Mengis Capital Management's Medtronic position peaked at $9.11M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Mengis Capital Management's 13F filing for Q1 2026, filed 12 May 2026.